Elizabeth L. Hohmann

Internal Medicine

55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance.

Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance.

Journal: Science translational medicine

Published: August 05, 2026

The Management of Fulminant C difficile Infection in an Immunocompromised Patient: Balancing Risk and Necessity.

The Management of Fulminant C difficile Infection in an Immunocompromised Patient: Balancing Risk and Necessity.

Journal: Gastroenterology

Published: April 23, 2026

Case 28-2025: A 36-Year-Old Man with Abdominal Pain, Fever, and Hypoxemia.

Case 28-2025: A 36-Year-Old Man with Abdominal Pain, Fever, and Hypoxemia.

Journal: The New England journal of medicine

Published: October 08, 2025

15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.

15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.

Journal: Nature medicine

Published: September 11, 2025

Practice Variations in the Management of Clostridioides difficile Infection: Findings From a Survey of US Physicians.

Practice Variations in the Management of Clostridioides difficile Infection: Findings From a Survey of US Physicians.

Journal: Gastro hep advances

Published: July 29, 2025

How and When to Use Microbial Restoration Therapies for Clostridioides difficile Infection.

How and When to Use Microbial Restoration Therapies for Clostridioides difficile Infection.

Journal: Annals of internal medicine

Published: June 16, 2025

Clostridioides difficile Infection: Harmonizing Patient Care.

Clostridioides difficile Infection: Harmonizing Patient Care.

Journal: Gastro hep advances

Published: June 09, 2025

Gut microbial ethanol metabolism contributes to auto-brewery syndrome in an observational cohort.

Gut microbial ethanol metabolism contributes to auto-brewery syndrome in an observational cohort.

Journal: Nature microbiology

Published: April 24, 2025

Lactobacillus Bacteremia and Endovascular Infections: A Retrospective Study of 100 Patients.

Lactobacillus Bacteremia and Endovascular Infections: A Retrospective Study of 100 Patients.

Journal: Open forum infectious diseases

Published: April 24, 2025

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.

Journal: Blood advances

Published: January 02, 2024

Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.

Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 14, 2023

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.

Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.

Journal: JAMA network open

Published: February 13, 2023

Showing 1-12 of 63

Last Updated: 09/26/2026